CTOs on the Move

Acer Therapeutics

www.acertx.com

 
Acer Therapeutics is a biotech company, headquartered in Cambridge, MA, that develops repurposed and reformulated medicines for the treatment of ultra-orphan diseases with significant unmet medical needs. Acer`s lead candidate, EDVISO™ (celiprolol), is the first pharmaceutical therapy seeking approval for patients with vascular-type Ehlers-Danlos syndrome (vEDS). Ehlers-Danlos Syndrome is a group of hereditary disorders of connective tissue with no ethnic predisposition. vEDS is a subtype characterized by severe arterial dissections, ruptures and early death. Complications are rare in childhood, but affect 25% of patients before the age of 20, and 80% by the age of 40. Median age of death ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.acertx.com
  • One Gateway Center, Suite 351 300 Washington Street
    Newton, MA USA 02458
  • Phone: 844.902.6100

Executives

Name Title Contact Details

Funding

Acer Therapeutics raised $48M on 03/07/2022

Similar Companies

GenRx Pharmacy

Welcome to GenRx Pharmacy in Scottsdale, AZ. Visit our website for our location, information and new patient sign ups.

Amplyx Pharmaceuticals

Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The resulting, new therapeutic creates a more targeted molecule with the goal of improving treatment outcomes and improving compliance with treatment regimens. Our initial development areas are in oncology and infectious disease.

Herbalife Manufacturing

Herbalife Manufacturing, LLC is a Lake Forest, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ICON Clinical Research

ICON Clinical Research is a North Wales, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dracen Pharmaceuticals

Dracen is a privately funded biotech company developing drugs in the area in of immuno metabolism.